Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.

Waheed S, Mitchell A, Usmani S, Epstein J, Yaccoby S, Nair B, van Hemert R, Angtuaco E, Brown T, Bartel T, McDonald J, Anaissie E, van Rhee F, Crowley J, Barlogie B.

Haematologica. 2013 Jan;98(1):71-8. doi: 10.3324/haematol.2012.066555. Epub 2012 Jun 24.

2.

¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.

Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V.

Clin Exp Med. 2015 Feb;15(1):1-18. doi: 10.1007/s10238-014-0308-3. Epub 2014 Sep 14. Review.

PMID:
25218739
3.

The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma.

Caers J, Withofs N, Hillengass J, Simoni P, Zamagni E, Hustinx R, Beguin Y.

Haematologica. 2014 Apr;99(4):629-37. doi: 10.3324/haematol.2013.091918. Review.

4.

Imaging patients with myeloma.

Winterbottom AP, Shaw AS.

Clin Radiol. 2009 Jan;64(1):1-11. doi: 10.1016/j.crad.2008.07.006. Epub 2008 Aug 29. Review.

PMID:
19070692
5.

¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review.

van Lammeren-Venema D, Regelink JC, Riphagen II, Zweegman S, Hoekstra OS, Zijlstra JM.

Cancer. 2012 Apr 15;118(8):1971-81. doi: 10.1002/cncr.26467. Epub 2011 Sep 1. Review.

6.

Current and future imaging modalities for multiple myeloma and its precursor states.

Tan E, Weiss BM, Mena E, Korde N, Choyke PL, Landgren O.

Leuk Lymphoma. 2011 Sep;52(9):1630-40. doi: 10.3109/10428194.2011.573036. Epub 2011 Jun 8. Review.

7.

[Imaging techniques in multiple myeloma].

Ozaki S.

Nihon Rinsho. 2007 Dec;65(12):2261-7. Review. Japanese.

PMID:
18069271
8.

Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques.

Rubini G, Niccoli-Asabella A, Ferrari C, Racanelli V, Maggialetti N, Dammacco F.

Crit Rev Oncol Hematol. 2016 May;101:169-83. doi: 10.1016/j.critrevonc.2016.03.006. Epub 2016 Mar 5. Review.

PMID:
26997302
9.

State-of-the-art of bone marrow imaging in multiple myeloma.

Martí-Bonmatí L, Ramirez-Fuentes C, Alberich-Bayarri Á, Ruiz-Llorca C.

Curr Opin Oncol. 2015 Nov;27(6):540-50. doi: 10.1097/CCO.0000000000000230. Review.

PMID:
26352540
10.

Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.

Lütje S, de Rooy JW, Croockewit S, Koedam E, Oyen WJ, Raymakers RA.

Ann Hematol. 2009 Dec;88(12):1161-8. doi: 10.1007/s00277-009-0829-0. Review.

11.

Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.

Pianko MJ, Terpos E, Roodman GD, Divgi CR, Zweegman S, Hillengass J, Lentzsch S.

Clin Cancer Res. 2014 Dec 1;20(23):5888-97. doi: 10.1158/1078-0432.CCR-14-1692. Epub 2014 Oct 7. Review.

12.

The role of imaging techniques in the management of multiple myeloma.

Zamagni E, Cavo M.

Br J Haematol. 2012 Dec;159(5):499-513. doi: 10.1111/bjh.12007. Epub 2012 Aug 11. Review.

PMID:
22881361
13.

Imaging of multiple myeloma and related plasma cell dyscrasias.

Walker RC, Brown TL, Jones-Jackson LB, De Blanche L, Bartel T.

J Nucl Med. 2012 Jul;53(7):1091-101. doi: 10.2967/jnumed.111.098830. Epub 2012 Jun 12. Review.

14.

Updated Diagnostic Criteria and Staging System for Multiple Myeloma.

Rajkumar SV.

Am Soc Clin Oncol Educ Book. 2016;35:e418-23. doi: 10.14694/EDBK_159009. Review.

15.

The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.

Terpos E, Dimopoulos MA, Moulopoulos LA.

Am Soc Clin Oncol Educ Book. 2016;35:e407-17. doi: 10.14694/EDBK_159074. Review.

16.

[The importance of imaging techniques in the modern treatment of multiple myeloma].

Jurczyszyn A, Małkowski B, Czepiel J, Skotnicki AB.

Przegl Lek. 2014;71(4):221-30. Review. Polish.

PMID:
25141582
17.

Imaging in multiple myeloma.

Delorme S, Baur-Melnyk A.

Recent Results Cancer Res. 2011;183:133-47. doi: 10.1007/978-3-540-85772-3_7. Review.

PMID:
21509684
18.

Molecular imaging in myeloma precursor disease.

Mena E, Choyke P, Tan E, Landgren O, Kurdziel K.

Semin Hematol. 2011 Jan;48(1):22-31. doi: 10.1053/j.seminhematol.2010.11.006. Review.

19.

Multiple myeloma: is it time for biomarker-driven therapy?

Bhutani M, Landgren O, Usmani SZ.

Am Soc Clin Oncol Educ Book. 2015:e493-503. doi: 10.14694/EdBook_AM.2015.35.e493. Review.

20.

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.

Dimopoulos M, Terpos E, Comenzo RL, Tosi P, Beksac M, Sezer O, Siegel D, Lokhorst H, Kumar S, Rajkumar SV, Niesvizky R, Moulopoulos LA, Durie BG; IMWG..

Leukemia. 2009 Sep;23(9):1545-56. doi: 10.1038/leu.2009.89. Epub 2009 May 7. Review.

PMID:
19421229

Supplemental Content

Support Center